Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9349607 | 0.82 | MAPK1 (0.39) | ESR1ESR2TSHRALDH1A1ALOX15 | |
| SCHEMBL14616390 | 0.80 | ALDH1A1 (0.43) | TSHRALDH1A1 | |
| SCHEMBL10484418 | 0.77 | ALDH1A1 (0.54) | TSHRALDH1A1ALOX15NPSR1 | |
| SCHEMBL9545770 | 0.74 | MAPK1 (0.43) | TSHRALDH1A1ALOX15 | |
| SCHEMBL4831574 | 0.72 | MAPK1 (0.56) | ESR1ESR2TSHRALDH1A1ALOX15 | |
| SCHEMBL11281234 | 0.72 | ESR1 (0.43) | ESR1ESR2TSHRALDH1A1NPSR1 | |
| SCHEMBL465848 | 0.72 | TSHR (0.52) | TSHREPHX2ALDH1A1 | |
| SCHEMBL20794689 | 0.72 | CA1 (0.44) | TSHREPHX2ALDH1A1ALOX15NPSR1 | |
| SCHEMBL18842007 | 0.71 | ALDH1A1 (0.34) | TSHRALDH1A1ALOX15NPSR1 | |
| SCHEMBL18841947 | 0.70 | TSHR (0.34) | TSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9790394-B2 | Floor coating compositions containing supramolecular polymers | ROHM AND HAAS COMPANY (US) | 2017-10-17 | — | — | US | disclosed |
| US-20120189860-A1 | POLYMERIC COMPOSITIONS COMPRISING POLYLACTIC ACID OLIGOMERS AND METHODS OF MAKING THE SAME | FINA TECHNOLOGY, INC. (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120085364-A1 | METHOD FOR MAKING UP EYELASHES | L'OREAL (FR) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120189860-A1 | POLYMERIC COMPOSITIONS COMPRISING POLYLACTIC ACID OLIGOMERS AND METHODS OF MAKING THE SAME | PUF60, PICALM, PARG | ESR1 4684/4885ESR2 4459/4885TSHR 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.